CORMEDIX INC (CRMD) Forecast, Price Target & Analyst Ratings

NASDAQ:CRMD • US21900C3088

Current stock price

7.22 USD
+0.05 (+0.7%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORMEDIX INC (CRMD).

Forecast Snapshot

Consensus Price Target

Price Target
$14.86
+ 105.86% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.48
Revenue Estimate
106.5M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.08%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.86
Upside
+ 105.86%
From current price of $7.22 to mean target of $14.86, Based on 13 analyst forecasts
Low
$13.13
Median
$14.28
High
$19.95

Price Target Revisions

1 Month
-1.92%
3 Months
-23.31%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for CRMD. The average price target is 14.86 USD. This implies a price increase of 105.86% is expected in the next year compared to the current price of 7.22.
The average price target has been revised downward by 23.31% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CRMD Current Analyst RatingCRMD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

CRMD Historical Analyst RatingsCRMD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.08%
CRMD was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRMD.
In the previous month the buy percentage consensus was at a similar level.
CRMD was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05NeedhamMaintains Buy -> Buy
2026-02-11D. Boral CapitalMaintains Buy -> Buy
2026-01-23HC Wainwright & Co.Maintains Buy -> Buy
2026-01-21RBC CapitalMaintains Outperform -> Outperform
2026-01-08D. Boral CapitalMaintains Buy -> Buy
2026-01-08NeedhamMaintains Buy -> Buy
2025-12-18D. Boral CapitalMaintains Buy -> Buy
2025-11-13HC Wainwright & Co.Maintains Buy -> Buy
2025-11-12D. Boral CapitalMaintains Buy -> Buy
2025-11-12NeedhamMaintains Buy -> Buy
2025-10-21RBC CapitalMaintains Outperform -> Outperform
2025-10-20D. Boral CapitalUpgrade Hold -> Buy
2025-09-09JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-08-08HC Wainwright & Co.Maintains Buy -> Buy
2025-06-30D. Boral CapitalDowngrade Buy -> Hold
2025-06-30HC Wainwright & Co.Initiate Buy
2025-06-24NeedhamMaintains Buy -> Buy
2025-06-23D. Boral CapitalMaintains Buy -> Buy
2025-06-20RBC CapitalReiterate Outperform -> Outperform
2025-05-07NeedhamMaintains Buy -> Buy
2025-05-06D. Boral CapitalMaintains Buy -> Buy
2025-04-09NeedhamReiterate Buy -> Buy
2025-04-08D. Boral CapitalMaintains Buy -> Buy
2025-03-26NeedhamMaintains Buy -> Buy
2025-03-26RBC CapitalReiterate Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.48
Revenue Estimate
106.5M
Revenue Q2Q
172.51%
EPS Q2Q
59.51%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
-4.10%
Revenue (3 Months)
-18.05%
EPS (1 Month)
-29.29%
EPS (3 Months)
-34.84%

Next Earnings Summary

CRMD is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.48 USD and the consensus revenue estimate is 106.50M USD.
The next earnings revenue estimate has been revised downward by 18.05% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRMD revenue by date.CRMD revenue by date.

-100.00%		43.472M311.709M
617.03%		312.65M
0.30%		295.89M
-5.36%		355.11M
20.01%		433.54M
22.09%		563.9M
30.07%		714.25M
26.66%		802.7M
12.38%		931.4M
16.03%
EBITDA
YoY % growth
CRMD ebitda by date.CRMD ebitda by date.
-48.887M
-60.08%		-22.047M
54.90%		164.69M
847.01%		125.12M
-24.03%		106.61M
-14.79%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CRMD ebit by date.CRMD ebit by date.
-48.958M
-59.89%		-22.356M
54.34%		150.141M
771.58%		91.795M
-38.86%		75.38M
-17.88%		116.63M
54.72%		193.92M
66.27%		305.61M
57.60%		436.3M
42.76%		511.12M
17.15%		616.5M
20.62%
Operating Margin
CRMD operating margin by date.CRMD operating margin by date.
N/A-51.43%48.17%29.36%25.48%32.84%44.73%54.20%61.09%63.68%66.19%
EPS
YoY % growth
CRMD eps by date.CRMD eps by date.
-0.92
-24.32%		-0.33
64.13%		2.02
712.12%		1.36
-32.63%		1.08
-20.74%		3.06
183.69%		1.93
-37.00%		3.93
103.70%		4.52
15.06%		5.04
11.51%		5.76
14.37%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.48
59.51%		0.40
41.71%		0.00
-100.17%		-0.02
-110.20%		0.11
-76.55%		0.10
-74.29%		0.07
3,371.03%		0.08
544.44%
Revenue
Q2Q % growth		106.5M
172.51%		96.997M
144.10%		54.714M
-47.53%		54.436M
-57.68%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		55.77M
174.90%		44.802M
125.49%		11.339M
-79.56%		10.654M
-85.54%		N/AN/AN/AN/A
EBIT
Q2Q % growth		49.877M
147.83%		36.6M
87.27%		1.309M
-97.45%		-986.34K
-101.67%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CRMD Yearly Revenue VS EstimatesCRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 200M 400M 600M 800M
CRMD Yearly EPS VS EstimatesCRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.85%
EPS Next 5 Year
14.22%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.93%
Revenue Next 5 Year
12.26%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CORMEDIX INC / CRMD Forecast FAQ

What is the price target for CRMD stock?

13 analysts have analysed CRMD and the average price target is 14.86 USD. This implies a price increase of 105.86% is expected in the next year compared to the current price of 7.22.

Can you provide the upcoming earnings date for CORMEDIX INC?

CORMEDIX INC (CRMD) will report earnings on 2026-05-04.

What are the consensus estimates for CRMD stock next earnings?

The consensus EPS estimate for the next earnings of CORMEDIX INC (CRMD) is 0.48 USD and the consensus revenue estimate is 106.50M USD.

What is the consensus rating for CRMD stock?

The consensus rating for CORMEDIX INC (CRMD) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.